InvestorsHub Logo

Cbdpotential

12/13/16 11:25 AM

#84033 RE: drv17 #84031

"SIGMACEPTOR is a high-throughput screening for discovering small molecule drugs with different affinity for targeting the sigma-1 receptor, and yes, it indeed can be outlicensed."